Yilei Mao Selected Research

Carcinogenesis

3/2024	PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1.
1/2020	Bioprinting of patient-derived in vitro intrahepatic cholangiocarcinoma tumor model: establishment, evaluation and anti-cancer drug testing.
8/2013	Effect of tomato extract supplementation against high-fat diet-induced hepatic lesions.
9/2010	Prediction and identification of tumor-specific noncoding RNAs from human UniGene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yilei Mao Research Topics

Disease

47	Neoplasms (Cancer) 01/2024 - 03/2008
38	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 11/2009
9	Cholangiocarcinoma 01/2024 - 01/2016
7	Inflammation (Inflammations) 01/2024 - 08/2011
7	Neoplasm Metastasis (Metastasis) 11/2023 - 07/2011
6	Liver Neoplasms (Liver Cancer) 03/2024 - 12/2010
6	Liver Failure 01/2021 - 04/2015
6	Fibrosis (Cirrhosis) 01/2020 - 12/2010
5	Hypertension (High Blood Pressure) 08/2022 - 01/2020
5	Liver Diseases (Liver Disease) 01/2021 - 05/2011
4	Carcinogenesis 03/2024 - 09/2010
4	Carcinoma (Carcinomatosis) 01/2022 - 08/2020
4	Hepatitis 01/2020 - 01/2016
3	Ascites 01/2024 - 04/2015
3	Fatigue 08/2022 - 08/2020
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 05/2011
3	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2016
2	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 10/2019
2	Body Weight (Weight, Body) 01/2023 - 01/2019
2	Gallbladder Neoplasms (Gallbladder Cancer) 08/2022 - 01/2021
2	Primitive Neuroectodermal Tumors (PNET) 01/2022 - 02/2013
2	Jaundice (Icterus) 01/2021 - 01/2020
2	Disease Progression 01/2021 - 01/2020
2	Fatty Liver 01/2020 - 01/2019
2	Hepatitis B 04/2016 - 04/2015
1	Microsatellite Instability 01/2024
1	Portal Hypertension 07/2023
1	Flatulence 03/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022
1	Necrosis 01/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022
1	Whooping Cough (Pertussis) 01/2022

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 10/2023 - 12/2010
11	Proteins (Proteins, Gene)FDA Link 12/2022 - 12/2010
8	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2019
8	lenvatinibIBA 06/2023 - 06/2018
7	AntigensIBA 01/2022 - 01/2020
6	RNA (Ribonucleic Acid)IBA 09/2022 - 10/2019
5	Tumor Biomarkers (Tumor Markers)IBA 03/2024 - 09/2010
5	CarbohydratesIBA 01/2022 - 01/2020
4	BilirubinIBA 08/2022 - 04/2015
4	AlbuminsIBA 01/2021 - 01/2016
4	Fetal Proteins (Fetoprotein)IBA 01/2021 - 06/2012
3	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 06/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 06/2016
3	LipidsIBA 01/2022 - 08/2013
3	Cell-Free Nucleic AcidsIBA 01/2021 - 04/2015
2	Biocompatible Materials (Biomaterials)IBA 06/2023 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 08/2021
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2022 - 12/2010
2	AntibodiesIBA 08/2022 - 08/2021
2	baysilon (polydimethylsiloxane)IBA 01/2022 - 11/2020
2	Oxygen (Dioxygen)IBA 01/2022 - 11/2020
2	Transaminases (Aminotransferases)IBA 08/2021 - 08/2020
2	GlypicansIBA 07/2021 - 03/2014
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2021 - 04/2016
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2016
2	EnzymesIBA 01/2020 - 01/2016
2	LigandsIBA 01/2019 - 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2024
1	TensinsIBA 03/2024
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2024
1	GalactosamineIBA 01/2024
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2024
1	LipopolysaccharidesIBA 01/2024
1	B7-H1 AntigenIBA 01/2024
1	Contrast MediaIBA 07/2023
1	entecavir FDA Link 02/2023
1	Tenofovir (Viread)FDA Link 02/2023
1	regorafenibIBA 01/2023
1	cabozantinibIBA 01/2023
1	Sunitinib (Sutent)FDA Link 11/2022
1	YttriumIBA 06/2022
1	HU 211 (HU 210)IBA 01/2022
1	NitrogenIBA 01/2022
1	Acarbose FDA LinkGeneric 01/2022
1	Leptin ReceptorsIBA 01/2022
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	lonidamineIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	rottlerinIBA 01/2022
1	Glucosylceramides (Glucocerebrosides)IBA 01/2022
1	MART-1 AntigenIBA 07/2021
1	Inhibins (Inhibin)IBA 07/2021
1	SynaptophysinIBA 07/2021

Therapy/Procedure

18	Therapeutics 06/2023 - 02/2013
12	Hepatectomy 09/2020 - 11/2009
8	Immunotherapy 01/2024 - 01/2019
3	Length of Stay 01/2024 - 04/2021
3	Transplantation 01/2021 - 03/2012
2	Drug Therapy (Chemotherapy) 11/2023 - 02/2013
2	Radiotherapy 06/2022 - 02/2013
1	Microbubbles 07/2023
1	Operative Surgical Procedures 03/2023
1	Microspheres (Microsphere) 06/2022